ARCH Venture Fund VIII, L.P.'s Net Worth

$269 Million

Who is ARCH Venture Fund VIII, L.P.?

ARCH Venture Fund VIII, L.P. has an estimated net worth of $269 Million. This is based on reported shares across multiple companies, which include Scholar Rock Holding Corp, Denali Therapeutics Inc., Metacrine, Inc., Codiak BioSciences, Inc., Sienna Biopharmaceuticals, Inc., and Homology Medicines, Inc..

SEC CIK

ARCH Venture Fund VIII, L.P.'s CIK is 0001605598

Past Insider Trading and Trends

2017 was ARCH Venture Fund VIII, L.P.'s most active year for acquiring shares with 1 total transactions. ARCH Venture Fund VIII, L.P.'s most active month to acquire stocks was the month of August. 2017 was ARCH Venture Fund VIII, L.P.'s most active year for disposing of shares, totalling 3 transactions. ARCH Venture Fund VIII, L.P.'s most active month to dispose stocks was the month of November. 2017 saw ARCH Venture Fund VIII, L.P. paying a total of $0.00 for 10,756,249 shares, this is the most they've acquired in one year. In 2017 ARCH Venture Fund VIII, L.P. cashed out on 10,756,249 shares for a total of $0.00, their largest year based on trade value.